Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...

One study found that a low level of fitness poses a greater risk of death over time than other traditional risk factors ...

Pain that persists one year after a heart attack can be linked to a significant risk of death at a level consistent with the ...

Acadian Ambulance recognized medics and Jeanerette fire chiefs for heroic actions that saved a man’s life after cardiac ...

Learn about Savithri's osteoporosis diagnosis, risk factors, prevention, and the impact of fractures on the elderly ...

Andhra Pradesh government allocates ₹194 crore for 100 new primary health centres, focusing on rural healthcare infrastructure development.

Arterial hypertension (high blood pressure) is one of the leading causes of cardiovascular disease and mortality worldwide.

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in ...

BROCK LESNAR has RETURNED to WWE for the first time in TWO YEARS at SummerSlam. The Beast Incarnate took out former WWE ...

Exclusive: GPs are coming under pressure to complete a death certificate when they are unsure of a patient’s cause of death.

Pacemaker implantations also surge Irfan Tramboo SRINAGAR, Aug 3: The Cardiology Department at the Super Speciality Hospital ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, tod ...